Abstract
AIMS: To determine a possible mechanism to explain the presence of aluminium lines within fully calcified bone in aluminium-related osteomalacia. METHODS: Fifty five bone cases shown by bone biopsy to be aluminium-related osteomalacia were studied. In 38 specimens aluminium lines were identified within calcified bone by means of the Aluminon stain and a characteristic form of patchy mineralisation was seen within thickened osteoid seams. Five representative examples were analysed quantitatively by histomorphometry and electronprobe X-ray microanalysis and compared with five cases of vitamin D deficiency-related osteomalacia which also had patchy mineralisation. RESULTS: The patchy calcification occupied 40 +/- 8% (mean +/- SEM) of the osteoid and consisted of small focal deposits (less than 40 microns diameter), often (52%) around osteoid osteocytes (probably an underestimate of the association), and larger areas that extended to the aluminium lines at the underlying mineralisation front. Small and large mineralisation nuclei were seen ultrastructurally in the patchy calcification. Quantitative electronprobe X-ray microanalysis showed that calcium concentrations and calcium:phosphorus ratios in the mineralisation nuclei and in the superficial layer of the fully calcified bone of the aluminium-related osteomalacia cases were significantly less than values measured at similar sites in the vitamin D deficiency-related osteomalacia cases. Furthermore, aluminium could not be detected by means of this technique at the mineralisation front or along cement lines in these specimens. CONCLUSIONS: Calcification can occur in thickened osteoid seams in osteomalacia. It can begin around osteoid osteocytes as small deposits that enlarge within the osteoid and extend to the underlying mineralisation front or cement line where aluminium lines may become trapped. Complete calcification of osteoid could account for the presence of aluminium lines within fully calcified bone. The Aluminon stain appears to be a more sensitive method for the detection of aluminium in bone than electronprobe X-ray microanalysis.
Full text
PDF






Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andreoli S. P., Bergstein J. M., Sherrard D. J. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med. 1984 Apr 26;310(17):1079–1084. doi: 10.1056/NEJM198404263101704. [DOI] [PubMed] [Google Scholar]
- Boyce B. F., Eider H. Y., Fell S. G., Nicholson W. A., Smith G. D., Dempster D. W., Gray C. C., Boyle I. T. Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy. Scan Electron Microsc. 1981;(Pt 3):329–337. [PubMed] [Google Scholar]
- Boyce B. F., Fell G. S., Elder H. Y., Junor B. J., Elliot H. L., Beastall G., Fogelman I., Boyle I. T. Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet. 1982 Nov 6;2(8306):1009–1013. doi: 10.1016/s0140-6736(82)90049-6. [DOI] [PubMed] [Google Scholar]
- Boyce B. F., Smith L., Fogelman I., Johnston E., Ralston S., Boyle I. T. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. Lancet. 1984 Apr 14;1(8381):821–824. doi: 10.1016/s0140-6736(84)92272-4. [DOI] [PubMed] [Google Scholar]
- Buchanan M. R., Ihle B. U., Dunn C. M. Haemodialysis related osteomalacia: a staining method to demonstrate aluminium. J Clin Pathol. 1981 Dec;34(12):1352–1354. doi: 10.1136/jcp.34.12.1352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charhon S. A., Chavassieux P. M., Chapuy M. C., Boivin G. Y., Meunier P. J. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. J Lab Clin Med. 1985 Aug;106(2):123–131. [PubMed] [Google Scholar]
- Charhon S. A., Chavassieux P. M., Chapuy M. C., Traeger J., Meunier P. J. High bone turnover associated with an aluminum-induced impairment of bone mineralization. Bone. 1986;7(5):319–324. doi: 10.1016/8756-3282(86)90250-4. [DOI] [PubMed] [Google Scholar]
- Charhon S. A., Chavassieux P., Boivin G., Parisien M., Chapuy M. C., Traeger J., Meunier P. J. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study. Clin Sci (Lond) 1987 Aug;73(2):227–234. doi: 10.1042/cs0730227. [DOI] [PubMed] [Google Scholar]
- Cournot-Witmer G., Zingraff J., Plachot J. J., Escaig F., Lefèvre R., Boumati P., Bourdeau A., Garabédian M., Galle P., Bourdon R. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int. 1981 Sep;20(3):375–378. doi: 10.1038/ki.1981.149. [DOI] [PubMed] [Google Scholar]
- Denton J., Freemont A. J., Ball J. Detection and distribution of aluminium in bone. J Clin Pathol. 1984 Feb;37(2):136–142. doi: 10.1136/jcp.37.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elliott H. L., Dryburgh F., Fell G. S., Sabet S., Macdougall A. I. Aluminium toxicity during regular haemodialysis. Br Med J. 1978 Apr 29;1(6120):1101–1103. doi: 10.1136/bmj.1.6120.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Felsenfeld A. J., Gutman R. A., Llach F., Harrelson J. M. Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis. Am J Nephrol. 1982;2(3):147–154. doi: 10.1159/000166631. [DOI] [PubMed] [Google Scholar]
- Maloney N. A., Ott S. M., Alfrey A. C., Miller N. L., Coburn J. W., Sherrard D. J. Histological quantitation of aluminum in iliac bone from patients with renal failure. J Lab Clin Med. 1982 Feb;99(2):206–216. [PubMed] [Google Scholar]
- Ott S. M., Maloney N. A., Coburn J. W., Alfrey A. C., Sherrard D. J. The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med. 1982 Sep 16;307(12):709–713. doi: 10.1056/NEJM198209163071202. [DOI] [PubMed] [Google Scholar]
- Platts M. M., Goode G. C., Hislop J. S. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J. 1977 Sep 10;2(6088):657–660. doi: 10.1136/bmj.2.6088.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ralston S. H., Boyce B. F., Cowan R. A., Fogelman I., Smith M. L., Jenkins A., Boyle I. T. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study. J Bone Miner Res. 1987 Feb;2(1):5–12. doi: 10.1002/jbmr.5650020103. [DOI] [PubMed] [Google Scholar]